baber/WOPTO huggingface dataset:
Patent CA-2577093-A1 (CA)
Inventor: AUGUSTINE SEBASTIAN P
IPC: C12G1/022
Filed: 2007-01-31
Abstract: The invention is related to the production of wine from tender coconut named tender coconut wine. The ingredients are Tender coconut water or tender coconut water and its soft kernel mix collected from farm fresh tender coconuts of seven months ripe or less, sugar, cinnamon, clove, dry vanilla, fruit juice etc. Pathimukam (cesalpina sappan), a natural coloring agent, is added for color during fermentation process. Tender coconut wines need a fermentation period of 10-28 days. The clarification is done with egg white after fermentation. For optional fortification, cashew apple alcohol or any such alcohol is added. As garden fresh tender coconuts are devoid of wild yeast and bacteria, wine made of it, will be automatically pure and natural.  The wine is a highly healthy, hygienic and nutritional beverage.
Patent CA-2577333-A1 (CA)
Inventor: WANKMUELLER JOHN
IPC: G06F21/34
Filed: 2005-08-18
Abstract: La présente invention a trait à un procédé et un appareil pour la réalisation d'une transaction sécurisée comprenant la génération d'un code d'authentification dynamique sur un dispositif mobile, basé sur une donnée secrète qui n'identifie pas un compte. Le code d'authentification et l'information d'identification de compte financier sont transmis à une entité de validation, qui partage une information concernant la donnée secrète, pour l'autorisation de la transaction.
Patent CA-2578859-A1 (CA)
Title: System and method for optical transmission
Inventor: BEST BRYANT A
IPC: H04B10/155
Filed: 2005-08-31
Abstract: An optical system that includes an analog laser transmitter having a burst operative mode is disclosed. The system further includes a power controller that is configured to place the analog laser transmitter in the burst operative mode when a digital enable signal is provided to the power controller. The power controller comprises a reference voltage source, a ground node, and an input selector switch that is configured to select the reference voltage source when the digital enable signal is asserted, and alternatively, to select the ground node when the digital enable signal is de-asserted. In a second exemplary embodiment, a method of operating an analog laser transmitter is disclosed. The method comprises providing an analog signal to the analog laser transmitter, and a digital enable signal to a controller circuit that is coupled to the analog laser transmitter. The method further comprises turning on the analog laser transmitter when the enable signal is asserted, and turning off the analog laser transmitter when the enable signal is de-asserted.
Patent CA-2580720-A1 (CA)
Title: System and method for variable depth ultrasound treatment
Inventor: SLAYTON MICHAEL H
IPC: A61N7/00
Filed: 2005-09-16
Abstract: A non-invasive variable depth ultrasound treatment method and system comprises a variable depth transducer system configured for providing ultrasound treatment to a patient. An exemplary variable depth transducer system can comprise a transducer configured to provide treatment to more than one region of interest, such as between a deep treatment region of interest and a superficial region of interest, and/or a subcutaneous region of interest. The variable depth transducer can comprise a transduction element having a piezoelectrically active layer, matching layers and/or other materials for generating radiation or acoustical energy. The variable depth transducer may be configured to operate at moderate frequencies within the range from approximately 750 kHz to 20 MHz or more. In addition, the transduction element may be configured with a variable depth device comprising one or more materials configured to allow for control and focusing/defocusing of the acoustic energy to more than one region of interest.
Patent CA-2581693-A1 (CA)
Title: New use
Inventor: WEBER GUENTHER
IPC: A61P31/04
Filed: 2005-07-26
Abstract: The present invention relates to the use of a vitamin D compound active in up-regulating the expression and production of hCAP18 in humans for the manufacture of a medicament for treatment of conditions deficient in or benefiting from LL-37. The vitamin D active compound can be used as a medicament for treatment of injured tissues, chronic ulcers, burn wounds, skin infections and atopic dermatitis and for improving the microvasculature. UVB  irradiation can also be used to up-regulate hCAP18.
Patent CA-2584644-A1 (CA)
Inventor: MCGEE THOMAS
IPC: C11D3/00
Filed: 2005-10-18
Abstract: A solid fabric softening composition which is suitable for adding to a heated tumble dryer along with fabric articles comprises a cationic softening agent, a sublimable carrier substance, silicone warm and a fragrance. The composition disintegrates to provide softening with good fragrance substantivity.
Patent CA-2586064-A1 (CA)
Inventor: GUENTHER SVEN
IPC: A61K38/16
Filed: 2005-11-02
Abstract: The present invention relates ribavirin delivery systems and more specifically to compositions that comprise amino acids, as single amino acids or peptides, covalently attached to ribavarin and methods for administering conjugated ribavirin compositions.
Patent CA-2587997-A1 (CA)
Inventor: HABERMAN LEONARD MICHAEL
IPC: C09K8/38
Filed: 2005-11-30
Abstract: A method is provided for drilling a wellbore including the steps of: providing a drilling mud comprising a primary amine; circulating the drilling mud while the wellbore is being drilled wherein the primary amine is incorporated into a filter cake deposited on the wellbore wall as the wellbore is being drilled;  and removing at least a portion of the filter cake after the wellbore is drilled by circulating fluid into the wellbore a composition comprising nitrous acid. The invention also includes the drilling fluid containing a solid component that generates gas from within the filter cake upon contact with a component that causes the solid component to generate gas. In some embodiments, the solid component is a primary amine grafted to a polymer that is not soluble in the drilling fluid composition such as a starch.
Patent CA-2589112-A1 (CA)
Title: Takraw balls
Inventor: LORHPIPAT BOONCHAI
IPC: B29C70/74
Filed: 2005-04-12
Abstract: A takraw is woven form takraw ball strips (10) of springy material having soft material pads (42) preferably mounted into recesses (30) in a strip face (28), the pads are, at least in part, bounded by strip face parts (32, 34, 36) which function to lend stifness to the strip, and/or protect pad edges and/or assist in mounting pads onto the strips.
Patent CA-2589283-A1 (CA)
Inventor: BAYMAN JOSEPH R
IPC: A61K31/075
Filed: 2005-12-22
Abstract: Novel packaging, methods of packaging and methods for storing thyroid hormone pharmaceutical compositions, such as levothyroxine (T4) sodium and liothyronine (T3) sodium, in reduced oxygen conditions for maintaining the stability and potency of the thyroid hormones during extended shelf life are provided.
Patent CA-2589712-A1 (CA)
Inventor: FROCK JEFFREY L
IPC: A47J27/04
Filed: 2007-05-24
Abstract: A steam generator for use with a steam cooker includes a heating chamber defining a volume for holding water. A heating system is associated with the heating chamber that is configured to heat water in the heating chamber so as to generate steam. An external probe housing unit is in communication with the heating chamber. The external probe housing unit includes a housing part defining a cavity therein. The housing part includes a first end through which water passes to and from the heating chamber, a second end opposite the first end, a top, a bottom and sides extending between the ends. A first probe support surface is located at a first probe receiving portion at the top of the housing part and a second probe support surface located at a second probe receiving portion at the top of the housing part. The first probe support surface is offset vertically from the second probe support surface
Patent CA-2590118-A1 (CA)
Title: Methode de coulage d'un element et element comprenant au moins partiellement du plastique stratifie renforce de fibres
Inventor: STIESDAL HENRIK
IPC: B29C70/06
Filed: 2007-05-24
Abstract: Linvention a trait à un procédé pour mouler un composant comprenant au moins partiellement un stratifié de plastique renforcé de fibres au moyen duquel le renfort de fibres (1) est disposé dans un moule de coulée (30, 31), dans lequel au moins un conduit de ventilation (2) est placé, ledit renfort de fibres (1) et ledit conduit de ventilation (2) étant au moins partiellement mouillés par le plastique (57) durant le procédé de coulée de telle manière que la ventilation seffectue par lintermédiaire dudit conduit de ventilation (2), et la surface du conduit de ventilation (2) est au moins partiellement constituée dune membrane semi-perméable qui permet le passage des gaz, mais ne permet pas le passage des plastiques ou en permet seulement le passage lent. De plus, linvention a trait à un composant comprenant au moins partiellement un stratifié de plastique renforcé de fibres, le stratifié de plastique (57) à lintérieur étant composé dun ou de plusieurs conduits de ventilation (2), la surface dun conduit de ventilation (2) étant au moins partiellement composée dune membrane semi-perméable qui permet le passage des gaz, mais ne permet pas le passage des plastiques ou en permet seulement le passage lent.
Patent CA-2592199-A1 (CA)
Title: Method for producing sheet-form electrolytic copper from halide solution
Inventor: TSUCHIYA HIROO
IPC: C25C7/08
Filed: 2007-06-18
Abstract: In a method for producing dense sheet-form electrolytic copper by electrowinning, the electrolyte contains a polyethylene glycol additive as a smoothening agent. In the prior art method, stirring is necessary. In an electrowinning method without stirring, the current concentrates on the edge portion of cathode 2. This current concentration is mitigated by means of conducting the electrolyzing current through a window 6b of a shielding plate 6 located in the vicinity of a cathode 2.
Patent CA-2592200-A1 (CA)
Title: Melangeur a lobes courbes pour tuyere a flux confluents de turbomachine
Inventor: VUILLEMIN ALEXANDRE ALFRED GAS
IPC: F01D25/30
Filed: 2007-06-18
Abstract: L'invention concerne un mélangeur (22) de turbomachine à double flux, comportant un organe cylindrique ayant à son extrémité aval une partie sinusoïdale définissant des lobes intérieurs (26) et des lobes extérieurs (28) répartis sur la circonférence, les lobes extérieurs (26) comportant chacun une paire de parois radiales (34a, 34b) reliées entre elles par un dôme curviligne extérieur (36), les lobes intérieurs (26) comportant chacun une paire de parois radiales (30) reliées entre elles par un dôme curviligne intérieur (32), les parois (34a, 34b) des lobes extérieurs étant disposées dans le prolongement radial des parois (30) des lobes intérieurs, les parois radiales (34a, 34b, 30) des lobes extérieurs (28) et des lobes intérieurs (26) présentant un contour sensiblement courbe ayant au moins un point d'inflexion (38a, 38b).
Patent CA-2594766-A1 (CA)
Inventor: ENGEL ROBERT
IPC: B01F23/10
Filed: 2005-12-13
Abstract: A device for providing a homogenous mixture of fuel and oxidant including an arrangement ( 5 ) for feeding liquid fuel to an evaporator, an arrangement ( 4 ) for feeding gaseous oxidant into a mixing zone ( 12 ) downstream of the evaporator, and a reaction zone downstream of the mixing zone in which a packed structure ( 3 ) is arranged. The packed structure can be a ceramic cylindrical molding having a diameter in the range 25 to 35 mm and an axial length in the range 15 to 50 mm or it can have flow conduits that are square in cross-section and have a cell density in the range 400 to 1200 cpsi.
Patent CA-2596921-A1 (CA)
Title: Medication delivery device
Inventor: CHAVEZ ENRICO
IPC: A61M5/145
Filed: 2006-01-27
Abstract: The medication delivery device is designed to receive a replaceable medication container and to determine an adjusted medication dose AD before each delivery of the medication contained in the medication container if the current content of the medication container is not a multiple of a prescribed dose D and is greater than the prescribed dose D. The adjusted medication dose AD is the dose to be delivered instead of the prescribed dose D during said medication delivery. The adjusted medication dose AD is determined by selecting one of a first dose, to that is higher than the prescribed dose D, and of a second dose, that is lower than the prescribed dose D, as a function of a variable B  that cumulates the values (AD - D).
Patent CA-2597029-A1 (CA)
Title: Copolymer of propylene or ethylene oxide and of an oxirane bearing an ionic group
Inventor: ALLOIN FANNIE
IPC: C08G65/24
Filed: 2006-02-09
Abstract: The invention relates to a copolymer of ethylene oxide or propylene oxide and at least one substituted oxirane bearing an ionic group. The copolymer is characterized in that its chain comprises repeat units —O—CH2—CH(—CH2—O—SO3−Li+)—, repeat units —O—CH2—CHR— in which R is H or CH3, optionally, repeat units —O—CH2—CH(—CH2R′)— in which R′ is a functional group. x Uses: electrolyte in electrochemical, selective-membrane and reference-membrane devices.
Patent CA-2597709-A1 (CA)
Title: A method of using a highly detailed, three dimensional, original, jewelry model to produce two different, thin walled, light weight expendable, thermoplastic replicas, castable inmetal
Inventor: NEWTON NANCY BLYTH
IPC: B22C13/08
Filed: 2007-09-10
Abstract: The present invention relates to a method of using a three dimensional master jewelry model and molds to produce two thin walled expendable replicas of the model, one of which, is facing the same direction as the model and the other one is facing a 180 degree opposite direction then casting the replicas in metal.
Patent CA-2599203-A1 (CA)
Inventor: LORENZON RAFFAELLE
IPC: E04D1/20
Filed: 2006-02-28
Abstract: A quadrilateral roofing tile characterised in that two parallel sides present their edges (8, 12, 34, 42) bent through 90~ in opposite directions to engage under traction with a first adjacent tile by means of ribs (10, 38) and complementary seats (14, 40), those edges comprising the seats being provided at their ends with apertures which can be superposed on portions of an adjacent second tile for engagement by roof fixing elements, and be covered by that bent edge of the first adjacent tile which comprises the ribs.
Patent CA-2600907-A1 (CA)
Inventor: MUTCH NICOLA J
IPC: C07K14/745
Filed: 2006-02-23
Abstract: L'invention concerne un réactif de thromboplastine comprenant (i) du TF, (ii) un phospholipide, et (iii) un bloqueur polyP TFPI.
Patent CA-2603277-A1 (CA)
Title: Method and system for facilitating timing of base stations in an asynchronous cdma mobile communications system
Inventor: CEDERVALL MATS
IPC: H04Q7/36
Filed: 1999-02-09
Abstract: A method for estimating relative timing of base stations in an asynchronous mobile communications system comprises receiving at a first mobile station first and second downlink signals transmitted by first and second base stations;  transmitting an uplink signal from the first mobile station to the first and second base stations; and calculating estimated relative time difference between the time bases of the first and second base stations using receive times at the first and second base stations of said uplink signal, transmit times of the first and second downlink signals, and a time difference at the first mobile station between a receive time of the second downlink signal and the transmit time of said uplink signal to account for propagation delays between first and second mobile stations.
Patent CA-2603734-A1 (CA)
Title: Nanoparticle-active ingredient conjugates
Inventor: JORDAN ANDREAS
IPC: A61K9/14
Filed: 2006-04-12
Abstract: The invention relates to nanoparticles, whereby at least one therapeutically active substance is bonded to the nanoparticles and the release of the therapeutically active ingredient is brought about or initiated by an alternating magnetic field. The invention further relates to pharmaceutical compositions, in particular, injection solutions comprising said nanoparticle and the use thereof for the treatment of cancer.
Patent CA-2604502-A1 (CA)
Title: Automated narration and recording for drive events
Inventor: TARABOCHIA DAVID
IPC: G08G1/0968
Filed: 2007-09-27
Abstract: Automatically presenting content to an occupant of a vehicle as the vehicle traverses a route (e.g., during a test drive or other drive event). Content items are associated with data tags placed throughout the route. A data tag reader on the vehicle reads each data tag as the vehicle traverses the route, and the content item associated with the read data tag is presented to the occupant of the vehicle.  In an embodiment, audio and/or video of the occupant is captured and stored on a computing device remote from the vehicle. The captured audio and/or video represent feedback from the occupant during the drive event.
Patent CA-2604843-A1 (CA)
Title: System and method for utilizing a wireless communication protocol in a communications network
Inventor: BATTA PUNEET
IPC: H04L29/06
Filed: 2006-04-11
Abstract: Described is a system including a wireless access point (20, 22, 24) and a computing device (30) . The wireless access point (20, 22, 24) has a first wireless protocol and communicates with a wireless device (10) which has a second wireless protocol. The access point (20, 22, 24) and the wireless device (10) are configured to conduct wireless communications using the first and second wireless protocols. The computing device (30) has a third wireless protocol and is coupled, via a wire, to the access point (20, 22, 24) . The computing device (30) conducts communications with at least one of the access point (20, 22, 24) and the wireless device (30) using the third wireless protocol .
Patent CA-2606773-A1 (CA)
Title: A method and arrangement for making a call-setup
Inventor: OLSSON ULF
IPC: H04L65/1096
Filed: 2006-06-19
Abstract: A method and arrangement for providing a ring-back presentation to a calling terminal after receiving a call setup request from the calling terminal (A) for a first communication session (308) with a called terminal (B) . A second packet-based communication session (310) is established with the calling terminal, independent of the first session, and pre-defined media content is provided as said ring-back presentation (312) to the calling terminal over the second session. Thereby, ring-back presentations to waiting callers can be selected from a great range of media types, including visual media. A calling user can also control the playout or display of the ring-back presentation irrespective of when the call is answered.
Patent CA-2610582-A1 (CA)
Inventor: CHEN ZESEN
IPC: H04L12/66
Filed: 2006-05-12
Abstract: VoIP traffic bandwidth through a router port is controlled so that it does not exceed a predetermined bandwidth to ensure a desired quality of service for all VoIP calls routed through the port. Information of a packet received by the port is extracted from a packet header. The information includes source and destination addresses and port numbers as well as the bandwidth used by the packet. If the packet is from an existing call, the packet is routed and the time the packet was received is updated. If the packet is from a new call, it is determined whether the port has sufficient bandwidth to route the new call. If the port has sufficient bandwidth, the packet is routed, bandwidth is allotted for subsequent packets from the new call, and the port information is updated to accept the subsequent packets.
Patent CA-2611891-A1 (CA)
Title: Analyte detection devices and methods with hematocrit/volume correction and feedback control
Inventor: STIVERS CAROLE R
IPC: G01N31/22
Filed: 2006-06-13
Abstract: An arrangement (10) for measuring the concentration of an analyte contained in a sample of body fluid includes: an assay pad (40) comprising at least one chemical reagent capable of producing a detectable signal in the form of a reaction spot (50) formed upon reaction with the analyte; a light source (32);  a detector array (20); a processor (84); and a memory (80) in communication with the processor. The memory (80) includes at least one value indicative of one or more of: (i) the level of hematocrit contained in the sample; (ii) the volume of the sample applied to the assay pad; or (iii) imperfections present in the reaction spot; and further including at least one algorithm for calculating the concentration of the analyte contained in the sample.  Alternatively, an arrangement (10) is described for measuring the concentration of an analyte contained in a sample of body fluid, the arrangement including: an assay pad (40) comprising at least one chemical reagent capable of producing a detectable signal in the form of a reaction spot (50) formed upon reaction with the analyte; a light source(32); a detector array (20); a processor (84); a memory (80) in communication with the processor; and at least one catalyst device constructed and arranged to be responsive to control signals.
Patent CA-2612357-A1 (CA)
Inventor: CHOUZENOUX CHRISTIAN
IPC: E21B47/12
Filed: 2007-11-26
Abstract: An apparatus for characterising the permeability of a formation surrounding a wellbore, comprising: a drillstem test (DST) tool comprising, a packer for isolating a zone of the wellbore, a valve for controlling fluid into and out of the zone via the drill string of the tool and, a pressure gauge for detecting the pressure in the zone; wherein the apparatus further comprises an array of at least two antennas arranged on the tool above the packer such that when in use each antenna of the array aligns with a corresponding pressure sensor placed in the formation to obtain pressure measurements and therefore allow horizontal and vertical permeability to be determined.
Patent CA-2617164-A1 (CA)
Title: Alcohol resistant pharmaceutical formulations
Inventor: MUHURI GOUTAM
IPC: A61P25/04
Filed: 2006-07-31
Abstract: The present invention provides alcohol resistant oral dosage pharmaceutical forms and methods of using such oral dosage forms to avoid dose dumping if the dosage form is taken together with alcohol.
Patent CA-2618566-A1 (CA)
Inventor: ZHANG XU-FANG
IPC: A61K31/40
Filed: 2006-08-07
Abstract: Certain 1H-indole-2-carboxylates and -2-carboxamides are HIV reverse transcriptase inhibitors. These indole compounds and their pharmaceutically acceptable salts are useful in the inhibition of HIV reverse transcriptase, the prophylaxis and treatment of infection by HIV and in the prophylaxis, delay in the onset, and treatment of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
Patent CA-2626299-A1 (CA)
Title: Flow based fair scheduling in multi-hop wireless networks
Inventor: SAMPATH HEMANTH
IPC: H04L12/56
Filed: 2006-09-01
Abstract: Embodiments describe flow based fair scheduling in a wireless multi-hop network. The scheduling can be rate controlled multi-hop scheduling or power controlled multi-hop scheduling. The scheduling chosen is intended to provide maxmin fairness over all flows within the wireless network.
Patent CA-2627672-A1 (CA)
Title: Method and device for verifying integrity of data acquisition pathways
Inventor: HAMA GORD
IPC: G06F17/40
Filed: 2008-03-26
Abstract: Disclosed is a method of verifying the integrity of data acquired from a device emulating a hard disk to a host computer over a data transfer pathway. A storage medium containing known data is connected to the data transfer pathway, the storage medium capable of emulating a hard disk. The known data is transferred from the storage medium to the host computer over the data transfer pathway for storage on the host computer. A  characteristic of the data stored on the host computer is compared with a corresponding characteristic of said known data to determine whether data corruption has occurred during data transfer over said data transfer pathway. The characteristic could be a hash code value, such as a Message--Digest 5(MD5) or Secure Hash Algorithm (SHA) value.